Onpattro (patisiran) a double-stranded small interfering ribonucleic acid (siRNA), formulated as a lipid complex injection.
Onpattro is a prescription medicine used to treat polyneuropathy (damage of multiple nerves throughout the body) in adults with hereditary transthyretin-mediated amyloidosis (hATTR).
Onpattro is given by intravenous (IV) infusion.
